REFERENCES
- 2020 GINA Main Report - Global Initiative for Asthma - GINA
[Internet]. [cited 2021 Feb 6]. Available
in: https://ginasthma.org/gina-reports/
- Coates AL, Wanger J, Cockcroft DW, Culver BH. Bronchoprovocation
Testing Task Force: Kai-Håkon Carlsen the BTT, Diamant Z, et al. ERS
technical standard on bronchial challenge testing: general
considerations and performance of methacholine challenge tests. Eur
Respir J 2017;49(5):1601526.
- Looijmans-Van Den Akker I, Van Luijn KRS, Verheij TJM. Overdiagnosis
of asthma in children in primary care: A retrospective analysis. BR J
Gen Pract. 2016;66(644):e152–7.
- Gaillard EA, Kuehni CE, Turner S, Goutaki M, Holden KA, de Jong CCM,
Lex C, H Lo D, Lucas J, Midulla F. European Respiratory Society
clinical practice guidelines for the diagnosis of asthma in children
aged 5–16 years. Eur Respir J 2021;2004173.
- Cockcroft DW. Direct Challenge Tests. Chest 2010;138(2):18S-24S.
- Selvanathan J, Aaron SD, Sykes JR, Vandemheen KL, FitzGerald JM,
Ainslie M, Lamier C, Filed S, MCIvor A, Hernandez P, et al.
Performance Characteristics of Spirometry With Negative Bronchodilator
Response and Methacholine Challenge Testing and Implications for
Asthma Diagnosis. Chest 2020;158(2):479–90.
- Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen K-H, Kaminsky DA,
Coates AL, Cockcroft DW, Culver BH, Diamant Z, et al. ERS technical
standard on bronchial challenge testing: pathophysiology and
methodology of indirect airway challenge testing. Eur Respir J
2018;52(5):1801033.
- Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement
of FEF25-75% and FEF75% does not contribute to clinical decision
making. Eur Respir J 2014;43(4):1051–8.
- Mallol J, Riquelme C, Aguirre V, Martínez M, Gallardo A, Sánchez C,
Córdova P. Value of bronchial reversibility to salbutamol, exhaled
nitric oxide and responsiveness to methacholine to corroborate the
diagnosis of asthma in children. Allergol Immunopathol (Madr). 1 de
mayo de 2020;48(3):214–22.
- Lukic KZ, Coates AL. Does the FEF 25-75 or the
FEF 75 have any value in assessing lung disease in
children with cystic fibrosis or asthma? Pediatr Pulmonol
2015;50(9):863–8.
- Cottini M, Lombardi C, Berti A CP. Small-airway dysfunction in
paediatric asthma. Curr Opin Allergy Clin Immunol 2021 Apr
1;21(2)128-134.
- Caussade S, Saavedra M, Barrientos H, Linares M, Aguirre V, Puppo H,
Lewinson D, Ubilla C, Meyer M, Moscoso G, et al. Comisión Función
Pulmonar Sociedad Chilena de Neumología Pediátrica. Neumol Pediatr
2019 14(1): 41-51.
- Graham BL, Steenbruggen I, Barjaktarevic IZ, Cooper BG, Hall GL,
Hallstrand TS, Kaminsky D, MCCarthy A, MCCormakc M, Oropez C, et al.
Standardization of spirometry 2019 update an official American
Thoracic Society and European Respiratory Society technical statement.
Am J Respir Crit Care Med 2019 ;200(8):e70-e88.
- Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright
P, Hankinson J, Ip M, Zheng J, Stocks J.
ERS
Global Lung Function Initiative. Multi-ethnic reference values for
spirometry for the 3–95-yr age range: the global lung function 2012
equations. Eur Respir J 2012 ;40(6):1324-43
- Davis BE, Cockcroft DW. Past, present and future uses of methacholine
testing. Expert Rev Respir Med 2012;6(3):321–9.
- Anderson SD. ‘Indirect’ challenges from science to clinical practice.
Eur Clin Respir J 2016;3(1):31096.
- Danvers L, Lo DKH, Gaillard EA. The role of objective tests to support
a diagnosis of asthma in children. Paediatr Respir Rev 2020;33:52-57
- Pellegrino R, Antonelli A, Crimi E, Gulotta C, Torchio R, Dutto L,
Pedersen O, Bursaco V. Dependence of bronchoconstrictor and
bronchodilator responses on thoracic gas compression volume.
Respirology. 2014;19(7):1040–5.
- Ciprandi G, Gallo F, Cirillo I. FEF25-75 and Asthma in Clinical
Practice. Iran J Allergy Asthma Immunol 2018;17(3):295–7.
- Lebecque P, Kiakulanda P, Coates AL. Spirometry in the asthmatic
child: is FEF25-75 a more sensitive test than FEV1/FVC? Pediatr
Pulmonol 1993;16(1):19–22.